Government funding to help UK development of greener inhalers
Kindeva Drug Delivery said it is aiming to manufacture inhalers with new propellants that have 90% lower global warming potential than the current greenest option used in the industry.
The NHS has identified that inhaler propellant gases make up around 3% of its carbon emissions
Shutterstock.com
The government has announced a £33m joint investment with a company that develops greener inhalers.
Get unlimited access to all content
You’ve reached your limit of premium articles on The Pharmaceutical Journal for this month.
